Message from the Director
The Center for Cancer Research and Therapeutic Development (CCRTD) was established at Clark Atlanta University (CAU) in 1999. It is funded by the NIH/NIMHD/RCMI and P20, NIH/NIMHD/U54, DOD, NIGMS, GRA and Clark Atlanta University. In 2004, CCRTD members made a unanimous decision to focus on prostate cancer -- a disease that disproportionately affects African-Americans and other minorities. The Center was designated as a Clark Atlanta University Center of Excellence in 2005 and 2012 and is the only research center at an HBCU in the United States concentrating specifically on prostate cancer.
The main objectives of CCRTD are to: 1) carry out state-of-the-art basic research in cancer biology; 2) to train undergraduate and graduate students and post-doctoral fellows in cancer research to prepare them as our next generation of scientists in biomedical research; and 3) to the establishment of a community-based cancer education and prevention program to build awareness about the dangers and prevalence of prostate cancer, as well as the benefits of early detection.
CCRTD is a vehicle of communication and collaboration for scientists at Clark Atlanta University who are interested in any aspect of cancer research. The biomedical research projects range from studies on signal transduction mechanisms to the development of better drug delivery systems. Our research agenda also includes investigations into the disparities between minority and majority populations in the incidence and/or severity of cancer.
It is the goal of the CCRTD to significantly increase the body of knowledge on cancer research, particularly as these diseases disproportionately impact the population mainly served by Clark Atlanta University, African Americans.
Shafiq A. Khan, PhD